• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Rapid growth in the COVID-19 era.新冠疫情时代的快速增长。
MRS Bull. 2021;46(9):847-853. doi: 10.1557/s43577-021-00185-2. Epub 2021 Sep 29.
2
"Warp Speed" Operations in the COVID-19 Pandemic: Moving Too Quickly?新冠疫情中的“极速行动”：是否推进过快？
JACC Basic Transl Sci. 2020 Jun 17;5(7):730-734. doi: 10.1016/j.jacbts.2020.06.001. eCollection 2020 Jul.
3
Vaccine Innovation for Pandemic Preparedness: Patent Landscape, Global Sustainability, and Circular Bioeconomy in Post-COVID-19 era.大流行防范的疫苗创新：后新冠疫情时代的专利格局、全球可持续性与循环生物经济
Circ Econ Sustain. 2021;1(4):1439-1461. doi: 10.1007/s43615-021-00051-y. Epub 2021 Jul 15.
4
The Future of Epidemic and Pandemic Vaccines to Serve Global Public Health Needs.满足全球公共卫生需求的流行性和大流行性疫苗的未来。
Vaccines (Basel). 2023 Mar 17;11(3):690. doi: 10.3390/vaccines11030690.
5
The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.新冠疫苗的快速研发和早期成功为加速癌症治疗机制带来了希望。
Arch Razi Inst. 2021 Mar;76(1):1-6. doi: 10.22092/ari.2021.353761.1612. Epub 2021 Mar 1.
6
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
7
Nano-Enabled COVID-19 Vaccines: Meeting the Challenges of Durable Antibody Plus Cellular Immunity and Immune Escape.纳米技术助力的新冠疫苗：应对持久抗体加细胞免疫及免疫逃逸挑战
ACS Nano. 2021 Apr 27;15(4):5793-5818. doi: 10.1021/acsnano.1c01845. Epub 2021 Apr 1.
8
Current and future nanoparticle vaccines for COVID-19.用于 COVID-19 的当前和未来纳米颗粒疫苗。
EBioMedicine. 2021 Dec;74:103699. doi: 10.1016/j.ebiom.2021.103699. Epub 2021 Nov 19.
9
mRNA and Adenoviral Vector Vaccine Platforms Utilized in COVID-19 Vaccines: Technologies, Ecosystem, and Future Directions.用于新冠疫苗的信使核糖核酸和腺病毒载体疫苗平台：技术、生态系统及未来方向
Vaccines (Basel). 2023 Nov 21;11(12):1737. doi: 10.3390/vaccines11121737.
10
Lessons from Biomedical Innovation during World War II.二战期间的生物医学创新的经验教训。
Hastings Cent Rep. 2021 Sep;51(5):3. doi: 10.1002/hast.1280.

引用本文的文献

1
Vaccine Innovation Meta-Model for Pandemic Contexts.大流行背景下的疫苗创新元模型
J Pharm Innov. 2023 Feb 13:1-49. doi: 10.1007/s12247-023-09708-7.
2
Impact of COVID-19 on materials science research innovation and related pandemic response.2019冠状病毒病对材料科学研究创新及相关疫情应对的影响。
MRS Bull. 2021;46(9):807-812. doi: 10.1557/s43577-021-00186-1. Epub 2021 Oct 12.

本文引用的文献

1
Lessons from the COVID-19 pandemic for advancing computational drug repurposing strategies.2019年冠状病毒病大流行对推进计算药物重新利用策略的启示。
Nat Comput Sci. 2021 Jan;1(1):33-41. doi: 10.1038/s43588-020-00007-6. Epub 2021 Jan 14.
2
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes.强效中和纳米抗体通过靶向多样化和保守的表位来抵抗 SARS-CoV-2 的集中循环变体。
Nat Commun. 2021 Aug 3;12(1):4676. doi: 10.1038/s41467-021-24963-3.
3
A Narrative Review of a Pulmonary Aerosolized Formulation or a Nasal Drop Using Sera Containing Neutralizing Antibodies Collected from COVID-19-Recovered Patients as a Probable Therapy for COVID-19.对含有从 COVID-19 康复患者中采集的中和抗体的血清制成的肺部雾化制剂或鼻腔滴剂作为 COVID-19 可能疗法的综述。
Iran J Med Sci. 2021 May;46(3):151-168. doi: 10.30476/ijms.2020.86417.1624.
4
Construction and Immunogenicity of Modified mRNA-Vaccine Variants Encoding Influenza Virus Antigens.编码流感病毒抗原的修饰mRNA疫苗变体的构建及免疫原性
Vaccines (Basel). 2021 May 3;9(5):452. doi: 10.3390/vaccines9050452.
5
Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses.吸入型纳米抗体（PiN-21）可在超低剂量下预防和治疗叙利亚仓鼠感染 SARS-CoV-2。
Sci Adv. 2021 May 26;7(22). doi: 10.1126/sciadv.abh0319. Print 2021 May.
6
Impact of lipid nanoparticle size on mRNA vaccine immunogenicity.脂质纳米颗粒大小对 mRNA 疫苗免疫原性的影响。
J Control Release. 2021 Jul 10;335:237-246. doi: 10.1016/j.jconrel.2021.05.021. Epub 2021 May 18.
7
How a historic funding boom might transform the US National Science Foundation.一场历史性的资金热潮可能如何改变美国国家科学基金会。
Nature. 2021 May;593(7857):19-20. doi: 10.1038/d41586-021-01076-x.
8
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials.羟氯喹和氯喹治疗 COVID-19 的国际合作随机试验荟萃分析的死亡率结果。
Nat Commun. 2021 Apr 15;12(1):2349. doi: 10.1038/s41467-021-22446-z.
9
SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63.SARS-CoV-2 mRNA 疫苗可诱导广泛的 CD4+ T 细胞反应，这些反应可识别 SARS-CoV-2 变体和 HCoV-NL63。
J Clin Invest. 2021 May 17;131(10). doi: 10.1172/JCI149335.
10
Racial and Ethnic Disparities in Years of Potential Life Lost Attributable to COVID-19 in the United States: An Analysis of 45 States and the District of Columbia.美国因 COVID-19 导致的潜在寿命损失的种族和民族差异：对 45 个州和哥伦比亚特区的分析。
Int J Environ Res Public Health. 2021 Mar 12;18(6):2921. doi: 10.3390/ijerph18062921.

新冠疫情时代的快速增长。

Rapid growth in the COVID-19 era.

作者信息

Lee Yerim, Ng Michelle, Daniel Kristin, Wayne Elizabeth

机构信息

Department of Biomedical Engineering, and Department of Chemical Engineering, Carnegie Mellon University, Pittsburgh, PA USA.

出版信息

MRS Bull. 2021;46(9):847-853. doi: 10.1557/s43577-021-00185-2. Epub 2021 Sep 29.

DOI:10.1557/s43577-021-00185-2
PMID:34608355
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8480751/
Abstract

ABSTRACT

From Operation Warp Speed to the lipid mRNA vaccine, the COVID-19 pandemic has been a watershed moment for technological development, production, and implementation. The scale and pace of innovation and global collaboration has likely not been experienced since World War II. This article highlights some of the engineering accomplishments that occurred during the pandemic. We provide a broad overview of the technological achievements in vaccine design, antibody engineering, drug repurposing, and rapid diagnostic testing. We also discuss what the future of these technologies and the future of large-scale collaborations might look like moving forward.

摘要

摘要

从“曲速行动”到脂质信使核糖核酸疫苗，新冠疫情成为了技术发展、生产和应用的一个分水岭时刻。自第二次世界大战以来，创新和全球合作的规模与速度可能从未有过。本文重点介绍了疫情期间取得的一些工程成就。我们对疫苗设计、抗体工程、药物再利用和快速诊断测试方面的技术成果进行了广泛概述。我们还讨论了这些技术的未来以及大规模合作的未来发展方向。